Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00512707 · ClinicalTrials.gov registry record · Phase 4
Effect of Testosterone in Men With Erectile Dysfunction
A Phase 4 study, sponsored by Boston University.
- Completed
- Registry status
- Phase 4
- Development phase
- 140
- Enrollment target
NCT00512707 is a Phase 4 study that has completed, run by Boston University. The registered enrollment target is 140 participants.
The verdict
NCT00512707, a Phase 4 study, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 140 participants
- Enrollment target
Study Summary
The purpose of this placebo-controlled study is to determine if testosterone replacement therapy, administered by transdermal gel, can improve the response to sildenafil (Viagra R) treatment in men who have erectile dysfunction (ED) and low testosterone levels.
Interventions
- DRUG Testosterone gel
- DRUG Sildenafil citrate (open label)
- OTHER Placebo gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2006-11 |
| Est. Completion | 2010-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00512707
The ClinicalTrials.gov registry entry for NCT00512707 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Testosterone gel is the first listed.
NCT00512707 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00512707 about?
NCT00512707 is a clinical study titled "Effect of Testosterone in Men With Erectile Dysfunction". The purpose of this placebo-controlled study is to determine if testosterone replacement therapy, administered by transdermal gel, can improve the response to sildenafil (Viagra R) treatment in men who have erectile dysfunction (ED) and low testosterone levels.
What is the current status of trial NCT00512707?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 140 participants. The study started on 2006-11. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00512707?
The interventions under investigation include: Testosterone gel (DRUG), Sildenafil citrate (open label) (DRUG), Placebo gel (OTHER).
Who is sponsoring clinical trial NCT00512707?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.